Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04950192 · ClinicalTrials.gov registry record
Philips Intracardiac Echocardiography (ICE) Clinical Registry
A clinical trial, sponsored by Philips Clinical & Medical Affairs Global.
- Completed
- Registry status
- 155
- Enrollment target
NCT04950192: Completed study, sponsored by Philips Clinical & Medical Affairs Global.
NCT04950192 is a clinical trial that has completed, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 155 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04950192 has completed, sponsored by Philips Clinical & Medical Affairs Global.
- COMPLETED
- Registry status
- 155 participants
- Enrollment target
Study Summary
The purpose of this observational registry is to report real-world safety and performance of VeriSight for ultrasound guided ICE imaging in percutaneous cardiac intervention procedures when used in standard clinical practice.
Primary Outcome
Investigator's assessment (Y/N) on successful delivery of VeriSight to the target intracardiac position and sustained device operation during the procedure
Interventions
- DEVICE ICE Image guidance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 155 participants |
| Start Date | 2021-10-25 |
| Est. Completion | 2023-07-30 |
What the finished NCT04950192 record still lists
NCT04950192 is an observational study that tracks outcomes without assigning an intervention. The registered 155 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which ICE Image guidance is the first listed.
NCT04950192 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04950192 about?
NCT04950192 is a clinical study titled "Philips Intracardiac Echocardiography (ICE) Clinical Registry". The purpose of this observational registry is to report real-world safety and performance of VeriSight for ultrasound guided ICE imaging in percutaneous cardiac intervention procedures when used in standard clinical practice.
What is the current status of trial NCT04950192?
This trial is currently completed. The enrollment target is 155 participants. The study started on 2021-10-25. Estimated completion is 2023-07-30.
What interventions are being tested in trial NCT04950192?
The interventions under investigation include: ICE Image guidance (DEVICE).
Who is sponsoring clinical trial NCT04950192?
This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03223610 · 155 participants · Phase 1
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
- NCT05072483 · 155 participants
Natural History Study of CADASIL
- NCT05086497 · 155 participants · NA
WBSI Guided Personalized Delivery of TTFields
- NCT05412069 · 155 participants · NA
Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI